Aptus Capital Advisors »

Viking Therapeutics shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4M 38k 63.31
2024-06-30 $1.5M 28k 53.01

More positions owned by Aptus Capital Advisors

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Broadcom (AVGO)
Apple (AAPL)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Etf Ser Solutions Aptus Enhanced (JUCY)
Ishares Tr Core Msci Intl (IDEV)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Etf Ser Solutions Aptus Large Cap (DUBS)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Etf Ser Solutions Aptus Drawdown (ADME)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Aptus Capital Advisors

Top funds holding Viking Therapeutics

FMR
Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Citadel Advisors
Jpmorgan Chase & Co
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Braidwell
Jane Street
Alliancebernstein
Westfield Capital Management Company
Invesco

View all funds holding Viking Therapeutics